Related Experiment Videos
[Bronchodilating effects of procaterol and aminophylline alone and in combination in asthmatic patients]
Nihon Kyobu Shikkan Gakkai Zasshi
|November 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection.
The Thoracic and cardiovascular surgeon·2006
Expression of basic fibroblast growth factor and its receptor-1 in cardiac myxoma.
The Journal of cardiovascular surgery·2002
[Peak expiratory flow (PEF)].
Nihon rinsho. Japanese journal of clinical medicine·2001
Early growth-response factor 1 and basic transcriptional element-binding protein 2 expression in cardiac allografts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001
[A case of expanding pulmonary aspergilloma].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[A case of allergic bronchopulmonary aspergillosis caused by Aspergillus terreus].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[Pulmonary thromboembolism associated with antiphospholipid syndrome in scleroderma].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[Clinical investigation of three cases of pulmonary eosinophilic granuloma].
Nihon Kyobu Shikkan Gakkai zasshi·1998
[A case of primary acute pulmonary cavitation in sarcoidosis complicated by multiple nodular lesions in the central nervous system].
Nihon Kyobu Shikkan Gakkai zasshi·1998
Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.
Expert opinion on pharmacotherapy·2026
New potassium binders: we need them-we do not need them.
Clinical kidney journal·2026
Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity.
Diabetes, obesity, and cardiometabolic CARE·2026
Ibogaine for Substance Use Disorders.
Advances in therapy·2026